5. Introduction

5. Introduction

There is no universally accepted definition of hyperkalaemia. This guideline has adopted the European Resuscitation Council (ERC) Guideline definition with a threshold serum potassium (K+) > 5.5 mmol/l, established in 20051 and maintained to the current date.2 It is further classified by severity into mild (5.5–5.9 mmol/l), moderate (6.0–6.4 mmol/l), and severe (≥ 6.5 mmol/l).

Hyperkalaemia is a common medical emergency when it presents acutely. The presence of persistent hyperkalaemia in the community is often regarded as chronic, usually in the context of drugs that exacerbate the condition.

The incidence of hyperkalaemia in the hospital setting ranges from 1.1% to 10%.3 5 The incidence in the community varies depending on the case mix of the population studied. The Chronic Kidney Disease Prognosis Consortium study showed that the prevalence of hyperkalaemia (K+ > 5.5 mmol/l) was 0.49% in the general population but was more prevalent in patients with CKD (4.2%).6 The prevalence of chronic hyperkalaemia in patients with CKD rises significantly with declining renal function.7

In hospital mortality is significantly higher in patients with hyperkalaemia (18.1%) compared to those with hypokalaemia (5.0%) or normokalaemia (3.9%).3 A U shaped association between serum K+ and mortality has been shown, including in patients with CKD and in patients receiving long term haemodialysis.8 Patients with severe hyperkalaemia (K+ > 6.5 mmol/l) are most at risk, and > 30% in hospital mortality has been reported.9, 10

The treatment of hyperkalaemia is still evolving as clinical experience is gained using new drugs and novel treatment approaches are developed. The key focus remains patient safety. Clinical decisions on when to treat and how aggressively to treat require a patient centred approach guided by the clinical setting and rate of change in serum K+ level. Patients with moderate levels of hyperkalaemia pose the greatest dilemma, especially when acuity is low, but warrant intervention to avoid deterioration. Severe hyperkalaemia risks arrhythmias and cardiac arrest; therefore, prompt recognition and intervention is required.

References

    1. Soar, J., et al., European Resuscitation Council Guidelines for Resuscitation 2005 Section 7. Cardiac arrest in special circumstances. Resuscitation, 2005. 67: p. S135 S170.
    2. Lott, C., et al., European Resuscitation Council Guidelines 2025 Special Circumstances in Resuscitation. Resuscitation, 2025. 215 Suppl 1: p. 110753
    3. Conway, R., et al., Serum potassium levels as an outcome determinant in acute medical admissions. Clin Med (Lond), 2015. 15(3): p. 239 43.
    4. Einhorn, L.M., et al., The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med, 2009. 169(12): p. 1156 62.
    5. Acker, C.G., et al., Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med, 1998. 158(8): p. 917 24.
    6. Kovesdy, C.P., et al., Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta analysis. Eur Heart J, 2018. 39(17): p. 1535 1542.
    7. Borrelli, S., et al., Chronic Hyperkalaemia in Chronic Kidney Disease: An Old Concern with New Answers. Int J Mol Sci, 2022. 23(12).
    8. Tafesse, E., et al., Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden. Eur Heart J Qual Care Clin Outcomes, 2022. 8(1): p. 61 69.Reference
    9. An, J.N., et al., Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care, 2012. 16(6): p. R225.
    10. Kuo, W.H., et al., Incidence, characteristics and outcomes among inpatient, outpatient and emergency department with reported high critical serum potassium values. Clin Chem Lab Med, 2021. 59(7): p. 1231 1237.